Core Insights - Ameris Bancorp (ABCB) is expected to report quarterly earnings of $1.15 per share, a 4.6% increase year-over-year, with revenues projected at $278.8 million, reflecting a 3.9% increase [1] - Analysts have revised the consensus EPS estimate upward by 0.8% over the past 30 days, indicating a collective reassessment of projections [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Financial Metrics - Analysts estimate a 'Net interest margin (TE)' of 3.6%, up from 3.5% a year ago [5] - The 'Efficiency ratio' is projected to be 56.6%, compared to 55.6% in the same quarter last year [5] - 'Nonaccrual loans' are expected to reach $98.61 million, down from $164.69 million in the same quarter last year [6] - The consensus for 'Average Balances - Total Earning Assets' is $24.22 billion, an increase from $23.21 billion a year ago [6] - 'Total non-performing assets' are projected at $125.21 million, down from $182.68 million in the same quarter last year [7] - 'Net Interest Income (TE)' is expected to be $214.47 million, compared to $202.34 million a year ago [7] - 'Total Non-Interest Income' is forecasted at $64.32 million, slightly down from $65.88 million a year ago [8] - 'Net Interest Income' is projected to reach $212.85 million, up from $201.39 million a year ago [8] Market Performance - Over the past month, Ameris Bancorp shares have declined by 8.7%, while the Zacks S&P 500 composite has decreased by 6.6% [9] - Based on its Zacks Rank 2 (Buy), Ameris Bancorp is expected to outperform the overall market in the upcoming period [9]

Core Viewpoint - Analysts project that Federated Hermes (FHI) will report quarterly earnings of $0.91 per share, reflecting a 2.3% year-over-year increase, with revenues expected to reach $421.56 million, a 6.4% increase from the same quarter last year [1] Earnings Projections - Over the past 30 days, the consensus EPS estimate has been adjusted downward by 7.5%, indicating a reassessment by covering analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Analysts estimate 'Revenue- Administrative service fees, net-affiliates' at $99.96 million, a year-over-year increase of 5.5% [5] - 'Revenue- Other service fees, net' is projected at $36.97 million, indicating a decrease of 0.9% from the prior-year quarter [5] - 'Revenue- Investment advisory fees, net' is expected to be $283.63 million, reflecting a 7.3% increase from the year-ago quarter [6] Asset Class Projections - 'Managed Assets - Long-term assets - Alternative/private markets' is estimated to be $20.00 billion, down from $20.47 billion reported in the same quarter last year [6] - 'Managed Assets - Long-term assets - Multi-asset' is projected at $2.91 billion, slightly down from $2.93 billion year-over-year [7] - 'Managed Assets - Money market' is expected to reach $634.16 billion, up from $578.81 billion a year ago [7] Fund Assets Estimates - 'Fund Assets - Funds - Long-term assets - Alternative/private markets' is projected at $12.20 billion, down from $12.46 billion year-over-year [8] - 'Fund Assets - Funds - long-term assets - Multi-asset' is expected to be $2.78 billion, slightly down from $2.79 billion [8] Separate Accounts Projections - 'Separate Accounts - Long-term assets - Alternative/private markets' is estimated at $7.80 billion, down from $8.01 billion year-over-year [9] - 'Separate Accounts - Long-term assets - Multi-asset' is projected at $127.93 million, down from $139 million in the same quarter last year [10] - 'Separate Accounts - Money market' is expected to reach $171.34 billion, up from $161.71 billion year-over-year [10] Stock Performance - Shares of Federated Hermes have decreased by 9.7% over the past month, compared to a 6.6% decline in the Zacks S&P 500 composite [11]

The upcoming report from Old National Bancorp (ONB) is expected to reveal quarterly earnings of $0.42 per share, indicating a decline of 6.7% compared to the year-ago period. Analysts forecast revenues of $478.3 million, representing an increase of 8.7% year over year.The current level reflects an upward revision of 4.4% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this ...

Core Viewpoint - Analysts forecast Intel (INTC) will report quarterly earnings of $0.01 per share, reflecting a year-over-year decline of 94.4%, with revenues expected to be $12.32 billion, down 3.2% from the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 2.1% in the last 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts estimate 'Net Revenues- Total Intel Products Group- Client Computing Group' will reach $6.86 billion, a year-over-year decline of 9% [5]. - 'Net Revenues- Total Intel Products Group- Network and Edge' is projected at $1.41 billion, reflecting a 3.1% increase from the prior year [5]. - 'Net Revenues- Total Intel Products Group- Data Center and AI' is expected to be $2.97 billion, indicating a 2% decline year-over-year [6]. - 'Net Revenues- Intel Foundry Services' is estimated at $4.25 billion, down 2.7% from the previous year [6]. - 'Net Revenues- All other- Mobileye' is projected to reach $449.28 million, suggesting an 88% increase year-over-year [6]. - The estimated 'Net Revenues- All other- Other' is $140.08 million, indicating a decline of 27.8% from the year-ago quarter [7]. Stock Performance - Intel shares have decreased by 21% in the past month, compared to a 6.9% decline in the Zacks S&P 500 composite [7].

Core Insights - Texas Instruments (TXN) is expected to report quarterly earnings of $1.06 per share, reflecting a year-over-year decline of 11.7% [1] - Anticipated revenues are projected to be $3.91 billion, indicating a 6.7% increase compared to the same quarter last year [1] Earnings Estimates - There has been no revision in the consensus EPS estimate over the last 30 days, suggesting stability in analysts' forecasts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong link between earnings estimate trends and short-term stock price movements [3] Revenue Projections - Analysts estimate 'Revenue- Other' at $213.26 million, representing a year-over-year increase of 23.3% [5] - The consensus for 'Revenue- Embedded Processing' is $608.48 million, indicating a decline of 6.7% from the prior year [5] - 'Revenue- Analog' is expected to reach $3.08 billion, reflecting an 8.6% increase from the year-ago quarter [5] Operating Profit Estimates - 'Operating Profit- Analog' is projected to be $1.10 billion, up from $1.01 billion in the same quarter last year [6] - 'Operating Profit- Other' is expected to be -$56.92 million, a significant decrease from the $173 million reported in the same quarter last year [6] - 'Operating Profit- Embedded Processing' is estimated at $90.08 million, down from $105 million in the same quarter last year [7] Stock Performance - Texas Instruments shares have decreased by 19.4% over the past month, compared to a 6.3% decline in the Zacks S&P 500 composite [8] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the overall market in the near future [8]

Core Insights - Wintrust Financial (WTFC) is expected to report quarterly earnings of $2.52 per share, a decline of 12.8% year-over-year, with revenues projected at $643.03 million, reflecting a 6.3% increase compared to the previous year [1] Earnings Projections - The consensus EPS estimate has remained unchanged over the past 30 days, indicating analysts have not revised their initial projections [2] - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3] Key Financial Metrics - Analysts estimate an 'Efficiency Ratio' of 57.6%, up from 55.2% a year ago [5] - The 'Net Interest Margin' is projected to be 3.5%, slightly down from 3.6% year-over-year [5] - 'Average balance - Total earning assets' is expected to reach $60.58 billion, compared to $52.27 billion last year [5] - The 'Tier 1 leverage ratio' is forecasted at 9.6%, up from 9.5% in the same quarter last year [6] - 'Total Non-Interest Income' is expected to be $127.46 million, down from $140.58 million a year ago [6] Income Estimates - 'Net interest income - FTE' is projected at $524.12 million, compared to $467 million last year [7] - 'Net Interest Income' is expected to reach $523.72 million, up from $464.19 million in the same quarter last year [7] - 'Service charges on deposit accounts' are estimated at $17.60 million, compared to $14.81 million a year ago [7] Additional Revenue Streams - 'Wealth management' is projected to reach $39.13 million, up from $34.82 million last year [8] - 'Mortgage banking' is expected to be $21.37 million, down from $27.66 million a year ago [8] - 'Operating lease income, net' is projected at $15.28 million, compared to $14.11 million last year [8] - 'Fees from covered call and put options' are expected to be $2.00 million, down from $4.85 million a year ago [9] Stock Performance - Over the past month, Wintrust shares have declined by 10.2%, while the Zacks S&P 500 composite has decreased by 3.9% [9] - Wintrust holds a Zacks Rank 2 (Buy), indicating a potential to outperform the overall market in the upcoming period [10]

Core Insights - Analysts project Kinder Morgan (KMI) will announce quarterly earnings of $0.35 per share, reflecting a year-over-year increase of 2.9% [1] - Revenue is expected to reach $4.14 billion, marking a 7.7% increase from the same quarter last year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.9% higher over the last 30 days, indicating a collective reevaluation by analysts [2] - Revisions to earnings projections are crucial for predicting investor behavior and are linked to short-term stock price performance [3] Key Metrics Analysis - Analysts estimate 'Terminals - Liquids leasable capacity' at 78.08 MMBBL, down from 78.6 MMBBL in the same quarter last year [5] - 'Segment EBDA- Products Pipelines' is projected to reach $284.28 million, compared to $292 million in the same quarter last year [5] - 'Segment EBDA- Terminals' is expected to be $269.13 million, slightly up from $269 million year-over-year [6] - 'Segment EBDA- Natural gas Pipelines' is forecasted at $1.56 billion, an increase from $1.51 billion year-over-year [6] - 'Segment EBDA- CO2' is anticipated to be $181.42 million, up from $158 million in the same quarter last year [6] Market Performance - Kinder Morgan shares have changed by -2.3% in the past month, compared to a -3.6% move of the Zacks S&P 500 composite [7] - With a Zacks Rank 2 (Buy), KMI is expected to outperform the overall market in the near future [7]

Core Insights - Analysts expect Johnson & Johnson (JNJ) to report quarterly earnings of $2.57 per share, reflecting a year-over-year decline of 5.2% [1] - Revenue projections stand at $21.66 billion, indicating a 1.3% increase from the previous year [1] - The consensus EPS estimate has been adjusted downward by 0.3% over the past 30 days, showing a reassessment by analysts [1] Revenue and Sales Estimates - The consensus estimate for 'Sales- MedTech- Total' is $8.16 billion, suggesting a year-over-year increase of 4.3% [3] - 'Sales- Innovative Medicine- WW' is projected to reach $13.49 billion, indicating a decline of 0.5% year over year [4] - 'Sales- MedTech- Surgery- WW' is expected to be $2.41 billion, also reflecting a decrease of 0.5% year over year [4] - 'Sales- Innovative Medicine- Oncology- WW' is forecasted to reach $5.58 billion, showing a significant increase of 15.9% from the previous year [4] Specific Product Sales Projections - 'Sales- Innovative Medicine- Oncology- CARVYKTI- WW' is estimated at $341.85 million, representing a substantial increase of 117.7% year over year [5] - 'Sales- Innovative Medicine- Neuroscience- SPRAVATO- WW' is projected to be $319.68 million, indicating a year-over-year increase of 42.1% [5] - 'Sales- MedTech- Cardiovascular- ABIOMED- WW' is expected to reach $408.39 million, reflecting a 10.1% increase year over year [6] - 'Sales- MedTech- Cardiovascular- Other Cardiovascular- WW' is estimated at $94.89 million, suggesting a 3.1% increase from the previous year [6] Orthopaedics Sales Estimates - 'Sales- MedTech- Orthopaedics- Hips- US' is projected at $268.43 million, indicating a decline of 0.6% year over year [7] - 'Sales- MedTech- Orthopaedics- Hips- International' is expected to be $154.50 million, reflecting a 1.6% increase year over year [7] - 'Sales- MedTech- Orthopaedics- Knees- US' is estimated at $240.27 million, suggesting a decrease of 0.7% year over year [8] Overall Performance and Market Position - Organic Sales Growth (Operational growth) is anticipated to reach 3.7%, slightly down from 3.9% reported in the same quarter last year [8] - JNJ shares have returned -7.3% over the past month, compared to a -5.3% change in the Zacks S&P 500 composite [8] - With a Zacks Rank 3 (Hold), JNJ is expected to perform in line with the overall market in the near future [8]

Wall Street analysts forecast that Wells Fargo (WFC) will report quarterly earnings of $1.23 per share in its upcoming release, pointing to a year-over-year decline of 2.4%. It is anticipated that revenues will amount to $20.8 billion, exhibiting a decline of 0.3% compared to the year-ago quarter.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 0.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projectio ...

Core Insights - Wall Street analysts anticipate Micron (MU) to report quarterly earnings of $1.43 per share, reflecting a year-over-year increase of 240.5% [1] - Expected revenues for the quarter are $7.9 billion, which represents a 35.6% increase from the same quarter last year [1] - The consensus EPS estimate has remained stable over the past 30 days, indicating a collective reevaluation by analysts [1] Revenue Projections - Analysts project 'Revenue by Technology- DRAM' to be $6.20 billion, indicating a year-over-year increase of 49.2% [4] - 'Revenue by Technology- Other (primarily NOR)' is expected to reach $93.87 million, suggesting a decline of 5.2% year over year [4] - 'Revenue by Technology- NAND' is forecasted to be $1.60 billion, reflecting a year-over-year increase of 2.4% [4] Market Performance - Micron shares have increased by 1.3% over the past month, contrasting with the Zacks S&P 500 composite's decline of 7.7% [5] - With a Zacks Rank of 4 (Sell), Micron is expected to underperform the overall market in the near term [5]